NCT00080002View on ClinicalTrials.gov

Efficacy of Pegamotecan (PEG-Camptothecin) in Localized or Metastatic Cancer of the Stomach or Gastroesophageal Junction

PHASE2TerminatedINTERVENTIONAL
Timeline

Start Date

December 31, 2003

Conditions
Cancer of StomachGastroesophageal Cancer
Interventions
DRUG

Pegamotecan

Sponsors
All Listed Sponsors
lead

Enzon Pharmaceuticals, Inc.

INDUSTRY